Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery... Show more
CZMWF's Aroon Indicator triggered a bullish signal on June 17, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 169 similar instances where the Aroon Indicator showed a similar pattern. In of the 169 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day RSI Indicator for CZMWF moved out of overbought territory on June 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CZMWF as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CZMWF turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
CZMWF moved below its 50-day moving average on June 30, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CZMWF crossed bearishly below the 50-day moving average on July 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.780) is normal, around the industry mean (24.348). P/E Ratio (33.670) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (3.778) is also within normal values, averaging (5.667). Dividend Yield (0.010) settles around the average of (0.018) among similar stocks. P/S Ratio (4.649) is also within normal values, averaging (42.660).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CZMWF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZMWF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVDL | 71.41 | 1.72 | +2.47% |
GraniteShares 2x Long NVDA Daily ETF | |||
EGGY | 39.17 | 0.94 | +2.45% |
NestYield Dynamic Income ETF | |||
EMSF | 27.55 | 0.10 | +0.37% |
Matthews Emerging Markets Sus Fut ActETF | |||
PSCH | 40.31 | 0.09 | +0.22% |
Invesco S&P SmallCap Health Care ETF | |||
GXUS | 51.77 | N/A | N/A |
Goldman Sachs MarketBeta(R) Ttl IntEqETF |
A.I.dvisor tells us that CZMWF and CZMWY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZMWF and CZMWY's prices will move in lockstep.
Ticker / NAME | Correlation To CZMWF | 1D Price Change % | ||
---|---|---|---|---|
CZMWF | 100% | N/A | ||
CZMWY - CZMWF | 23% Poorly correlated | -4.93% | ||
SMMNY - CZMWF | 20% Poorly correlated | -1.31% | ||
FONR - CZMWF | 20% Poorly correlated | +1.23% | ||
CLPBY - CZMWF | 17% Poorly correlated | -1.27% | ||
CLPBF - CZMWF | 12% Poorly correlated | N/A | ||
More |